Silver Sponsor

Welcome to PharmaBlue

A Partner for Innovative Pharmaceutical Companies

We are your Medium/Long term partner to get and run your Early Access Program in France.

We provide Exploitant services to our clients for rapidly marketing their approved medicines in France (orphan or unmet medical need).


What is our mission?

"PharmaBlue aims to contribute to a world where patients with unmet medical needs have better access to a variety of safe, effective healthcare products, and innovative treatments."


Why Partner with PharmaBlue?

1.Why choosing France for your EAP?

France have very specific local regulations for such programs since the new reform in July 2021:

  • Faster access to innovative treatments for patients with unmet medical need
  • Attractive to pharmaceutical companies
  • Financially sustainable for the French healthcare systems and pharma companies

2. What are the benefits?

  • Allowing continuous access to the investigational drug for patients
  • Building the company image before commercial launch
  • Generate turnover before marketing approval by regulatory agencies
  • Setting the scene for future market access of commercial product

3. Why should you work with us?

  • Immediate activation of French Affiliate – Exploitant Status
  • Access to Rare Skills & Experienced Early Access Team in France
  • Peace of mind operations on the French market


Learn more about on EAP in France and how you could benefit from it.

Watch our video:

Visit our website:

Contact us:





Get Involved At World Orphan Drug Congress USA


To Sponsor Or Exhibit


Justin Franks
t/ +1 914 819 3506




To Speak


Gina McHugh
t/ +1 646 619 1775




Marketing & Press Opportunities


Kaylie Brogan